[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Sangui BioTech International Inc (SGBI) - Financial and Strategic SWOT Analysis Review

October 2021 | 34 pages | ID: S9952B5975AEN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Sangui BioTech International Inc (SGBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Sangui Biotech International Inc (Sangui Biotech), formerly Citadel Investment System, Inc, is a pharmaceutical company that develops novel and proprietary pharmaceuticals, medical products and cosmetics. Sangui Biotech's product portfolio includes artificial oxygen carriers, nano formulations for the regeneration of skin, wound pads and wound spray. It also markets wound dressing products to support wound healing process in the name of chitoskin. The company develops oxygen carriers that can transport oxygen in acute and chronic conditions such as arterial blockage or anemia following injury, surgery, or other causes in humans. It markets the products in European countries, and Mexico through its subsidiary, and network of distribution partners. Sangui Biotech is headquartered in Hamburg, Germany.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Sangui BioTech International Inc - Key Facts
Sangui BioTech International Inc - Key Employees
Sangui BioTech International Inc - Key Employee Biographies
Sangui BioTech International Inc - Major Products and Services
Sangui BioTech International Inc - History
Sangui BioTech International Inc - Company Statement
Sangui BioTech International Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Sangui BioTech International Inc - Business Description
R&D Overview
Sangui BioTech International Inc - Corporate Strategy
Sangui BioTech International Inc - SWOT Analysis
SWOT Analysis - Overview
Sangui BioTech International Inc - Strengths
Sangui BioTech International Inc - Weaknesses
Sangui BioTech International Inc - Opportunities
Sangui BioTech International Inc - Threats
Sangui BioTech International Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sangui BioTech International Inc, Recent Deals Summary

SECTION 5 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Sangui BioTech International Inc, Key Facts
Sangui BioTech International Inc, Key Employees
Sangui BioTech International Inc, Key Employee Biographies
Sangui BioTech International Inc, Major Products and Services
Sangui BioTech International Inc, History
Sangui BioTech International Inc, Subsidiaries
Sangui BioTech International Inc, Key Competitors
Sangui BioTech International Inc, Ratios based on current share price
Sangui BioTech International Inc, Annual Ratios
Sangui BioTech International Inc, Annual Ratios (Cont...1)
Sangui BioTech International Inc, Interim Ratios
Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sangui BioTech International Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Sangui BioTech International Inc, Performance Chart (2017 - 2021)
Sangui BioTech International Inc, Ratio Charts
Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021


More Publications